Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
27.1M
-
Number of holders
-
141
-
Total 13F shares, excl. options
-
26.6M
-
Shares change
-
-28.4K
-
Total reported value, excl. options
-
$281M
-
Value change
-
-$6.2M
-
Put/Call ratio
-
0.31
-
Number of buys
-
65
-
Number of sells
-
-72
-
Price
-
$10.59
Significant Holders of Arcturus Therapeutics Holdings Inc. - Common Stock (ARCT) as of Q1 2025
179 filings reported holding ARCT - Arcturus Therapeutics Holdings Inc. - Common Stock as of Q1 2025.
Arcturus Therapeutics Holdings Inc. - Common Stock (ARCT) has 141 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 26.6M shares
of 27.1M outstanding shares and own 97.93% of the company stock.
Largest 10 shareholders include FEDERATED HERMES, INC. (4.69M shares), BlackRock, Inc. (2.76M shares), ARK Investment Management LLC (2.01M shares), Sumitomo Mitsui Trust Group, Inc. (1.93M shares), Nikko Asset Management Americas, Inc. (1.93M shares), VANGUARD GROUP INC (1.75M shares), STATE STREET CORP (1.28M shares), Balyasny Asset Management L.P. (938K shares), Schonfeld Strategic Advisors LLC (826K shares), and Woodline Partners LP (780K shares).
This table shows the top 141 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.